October 18, 2021

Seglentis Approved to Manage Acute Pain

Read More
October 18, 2021

Tyrvaya Becomes First FDA-Approved Nasal Spray for Dry Eye Disease

Read More
October 18, 2021

HIV Treatment Biktarvy Approved to Treat Younger Children

Read More
October 18, 2021

Cyltezo Will Be Interchangeable with Humira at the Pharmacy

Read More
October 15, 2021

Tecentriq Granted New Indication for Non-Small Cell Lung Cancer

Read More
October 14, 2021

Lupin Pharmaceuticals Recalls All Irbesartan and Irbesartan/HCTZ

Read More
October 12, 2021

Teligent Recalls Five Additional Lots of Lidocaine Topical Solution

Read More
October 11, 2021

FDA Approves Novel Treatment for Rare Immune Disorder in Children

Read More
October 11, 2021

Dextenza Approved to Treat Itching in the Eye Caused by Allergies

Read More
October 8, 2021

First New Treatment in a Decade for ANCA-Vasculitis Approved

Read More
October 5, 2021

Tecartus Granted New Leukemia Indication

Read More
October 5, 2021

Medtronic Expands Class I Recall of Insulin Pumps

Read More